ArticleCureus2026
Successful Treatment With Rituximab for Severe Immune Thrombocytopenic Purpura During Hemodialysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune thrombocytopenic purpura (ITP), an autoimmune disorder characterized by peripheral platelet destruction, is uncommon in patients undergoing hemodialysis, who have an inherently elevated bleeding risk. We report a case of severe ITP in a 68-year-old woman on maintenance hemodialysis for 10 years due to myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis, treated with rituximab. Three years before admission, she was diagnosed with rheumatoid arthritis (RA) and had unexplained thrombocytopenia that improved with prednisolone, resolving her arthritis. The disease activity of both MPO-ANCA-associated vasculitis and RA was later controlled without prednisolone. Four months prior, her platelet count suddenly dropped to 54,000/μL. Laboratory tests showed elevated platelet-associated IgG (PA-IgG), increased bone marrow megakaryocytes, negative antinuclear antibody, MPO-ANCA, anti-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.